Self-amplifying mrna covid-19 vaccine demonstrates superior immune response compared with mrna vaccine at 12 months post-vaccination

Head-to-head data, presented at options xii for the control of influenza conference, demonstrates advantage of sa-mrna over conventional mrna in duration of immune response; results highlight csl and arcturus therapeutics' commitment to advancing covid-19 vaccine innovation to protect public health. waltham, mass.
ARCT Ratings Summary
ARCT Quant Ranking